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Abstract
Background: Animal African trypanosomiasis, sleeping sickness in humans and Nagana in cattle, is a resurgent
disease in Africa caused by Trypanosoma parasites. Trans-sialidases expressed by trypanosomes play an important
role in the infection cycle of insects and mammals. Whereas trans-sialidases of other trypanosomes like the
American T. cruzi are well investigated, relatively little research has been done on these enzymes of T. congolense.
Results: Based on a partial sequence and an open reading frame in the WTSI database, DNA sequences encoding
for eleven T. congolense trans-sialidase 1 variants with 96.3% overall amino acid identity were amplified. Trans-
sialidase 1 variants were expressed as recombinant proteins, isolated and assayed for trans-sialylation activity. The
purified proteins produced a2,3-sialyllactose from lactose by desialylating fetuin, clearly demonstrating their trans-
sialidase activity. Using an HPLC-based assay, substrate specificities and kinetic parameters of two variants were
characterized in detail indicating differences in substrate specificities for lactose, fetuin and synthetic substrates.
Both enzymes were able to sialylate asialofetuin to an extent, which was sufficient to reconstitute binding sites for
Siglec-4. A mass spectrometric analysis of the sialylation pattern of glycopeptides from fetuin revealed clear but
generally similar changes in the sialylation pattern of the N-glycans on fetuin catalyzed by the trans-sialidases
investigated.
Conclusions: The identification and characterization of a trans-sialidase gene family of the African parasite T.
congolense has opened new perspectives for investigating the biological role of these enzymes in Nagana and
sleeping sickness. Based on this study it will be interesting to address the expression pattern of these genes and
their activities in the different stages of the parasite in its infection cycle. Furthermore, these trans-sialidases have
the biotechnological potential to be used for enzymatic modification of sialylated glycoconjugates.
Background
Animal African trypanosomiasis, called sleeping sickness
in humans and Nagana in cattle, is a resurgent disease
in Africa. Nagana is caused by Trypanosoma congolense
(T. congolense), Trypanosoma vivax (T. vivax)a n dTry-
panosoma brucei (T. brucei) subspecies. Most research
on African trypanosomes has focused on T. brucei,
whereas only few studies have been done with other
African trypanosomes including T. congolense. In wild
animals, these parasites cause relatively mild infections
while in domestic animals they cause a severe, often
fatal disease. Because of Nagana, stock farming is very
difficult within the tsetse belt of Africa [1].
Although of crucial importance for their survival,
cyclical transmission and hence pathogenicity of trypa-
nosomes, trypanosomes lack the biochemical metabolic
machinery synthesizing sialic acids (Sia), but use a
unique enzyme, trans-sialidase (TS) to transfer Sia onto
the parasites surface molecules from the environment.
Structurally TS belong to the family of sialidases (SA).
In contrast to the usual sialyltransferases, TS does not
utilize CMP-activated Sia as monosaccharide donors,
but catalyzes the transfer of carbohydrate-linked Sia to
another glycan forming a new a2,3-glycosidic linkage to
galactose or N-acetylgalactosamine.
Whereas more detailed studies exist on the role of TS
in the pathogenicity of T. cruzi, the etiologic agent of
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discovered [2], the current knowledge about the corre-
sponding enzymes in the African trypanosomes is very
limited. Of all the African trypanosomes, only T. brucei
full length TS genes have been cloned and studied [3].
Sialylation of parasite surfaces is believed to protect the
parasites from the action of glycolytic enzymes as well
as from immunocompetent substances present in the
tsetse gut and blood meal respectively, as well as influ-
encing the interaction of parasites with the gut epithelial
cells [4-6]. In the African trypanosomes where TS is
thought to be expressed only in the procyclic insect
stages [5,7], TS has been shown to increase the survival,
maturation and hence establishment of the parasites in
the vector midgut [8].
Two TS forms, named TS-form 1 and TS-form 2,
have been purified from procyclic T. congolense cultures
[6]. Interestingly, glutamic acid and alanine-rich protein
(GARP) was co-purified with TS-form 1, suggesting that
G A R Pm a yb ean a t u r a ls u b s t r ate for TS-form 1. Inter-
estingly, TS-form 1 had significantly less SA activity and
higher TS activity, whereas SA activity was predomi-
nately found in preparations of TS-form 2. An anti-T.
congolense TS antibody (mAb 7/23) was developed using
T Sf o r m1a sa n t i g e n .T h i sa n t i b o d yi ss p e c i f i cf o rT.
congolense TS recognizing TS-form 1 and TS-form 2,
but does not bind to T. brucei TS. Peptides micro
sequencing revealed the amino acid sequence
VVDPTVVAK in TS-form 1. Subsequently, fragments of
two TS genes (TS1 and TS2) were sequenced, sharing
about 50% sequence identity [9]. TS1 encoded this pep-
tide sequence, whereas in TS2 this sequence ended in
VVK. These data strongly suggested that the gene pro-
duct of TS1 has been present in TS-form 1. Neverthe-
less, it has remained unclear whether only TS1 and/or
TS2 gene products were present in TS-form 1 and TS-
form 2 preparations. Due to the fact that the monoclo-
nal antibody mAb 7/23 bound both TS preparations, it
is quite possible that TS-form 2 contained at least some
amounts of TS1 gene product, which might have been
responsible for the TS activity of this preparation.
Here, we report the cloning of eleven trans-sialidase
TS1 variants from T. congolense and their recombinant
expression in CHOLec1 cells. Furthermore, the enzymatic
properties of two of these recombinant TS1 variants
were compared with TS from T. cruzi.
Results
Diversity of TS1 genes and structural model
Based on the partial sequence of TS1 [GenBank:
AJ535487.1] [9], an open reading frame in the Welcome
Trust Sanger Institute (WTSI) database was identified.
The full-length translation product consists of 750
amino acids extending the partial sequence of TS1 by
153 amino acids at the N-terminus and by 84 amino
acids at the C-terminus. It contains a 16 amino acids N-
terminal signal peptide and a catalytic domain (residues
17-467), which is connected through a long a helix
(residues 468-491) to a lectin domain (residues 492-732)
followed by a potential C-terminal GPI-anchor attach-
ment site (residues 733-750, identified by big-PI predic-
tor [10]). Furthermore, nine potential N-glycosylation
sites were identified (Figure 1).
T. congolense TS1 shares about 57% sequence identity
with T. brucei TS [EMBL: AAG32055.1] and 48% with
T. cruzi TS [EMBL: BAA09334.1] (Figure 2). The T.
brucei TS has a prolonged N-terminus of approx. 90
a m i n oa c i d s ,w h i c hi sc o n s e r v e di nT. congolense TS1
sharing 50% amino acids, but is absent in T. cruzi TS.
The catalytic domain of both African proteins has 60%
and the lectin domain 43% sequence similarities. T. con-
golense TS1, like T. brucei TS and T. rangeli SA, has no
C-terminal SAPA domain typical for T. cruzi TS [11].
Almost all amino acid residues reported to be required
for TS activity are identical in TS1 with the exception of
A325 (corresponding to P231 in T. cruzi TS) [11], R127,
G344-Q346 and Y408 (corresponding to Y248 and
W312, respectively in T. cruzi TS) [12] (Figure 2).
To produce recombinant protein for enzyme charac-
terization, the DNA encoding amino acids 17-732 was
amplified using genomic T. congolense DNA as a tem-
plate and inserted into a mammalian expression vector
as described in Methods. 13 clones were picked from
two independent cloning experiments and sequenced.
Interestingly, not all the 13 clones had identical
sequences and eleven different sequences were obtained
(TS1a through TS1j), exhibiting an overall amino acid
identity of 96.3%. A more detailed search of the WTSI
database using these sequences as queries confirmed the
presence of these TS1 genes in the T. congolense gen-
ome database. As shown in Figure 3, changes are not
evenly distributed over the protein sequences. Eight
were found in the lectin domain and 17 in the catalytic
domain, some close to the predicted active site as
shown in Figure 4A.
For a better understanding of how these differences
may affect TS function, we calculated a model structure
(Figure 4) for TS1 e-1 by homology modeling based on
the crystal structure of T. cruzi TS [12], which was com-
plexed with the Sia derivative 3-fluoro-5-N-acetyl-9-ben-
zamido-2,9-dideoxy-neuraminic acid. The superimposed
structures of T. cruzi TS and the T. congolense TS1 e-1
model had a root mean square deviation (RMSD) of
0.685 Å over 594 aligned residues.
In Figure 4A, amino acids of the active site are high-
lighted. Most of the amino acids reported to be relevant
for TS activity are identical in all T. congolense TS1 var-
iants (white labels). However, differences to T. cruzi TS
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Page 2 of 16were identified at three positions (yellow labels in Figure
4A). (I) At position 325 all T. congolense TS1 variants
have an alanine, like in T. brucei TS, replacing a proline
occurring in T. cruzi TS (P231); (II) Y408 of all T. con-
golense TS1 variants corresponds to a tryptophan in T.
cruzi TS (W321) and T. brucei TS; (III) the group of
G342, G343 and Q344 replaces a tyrosine (Y248) in T.
cruzi TS. In addition, near the catalytic site at position
407 (red label) in T. congolense TS1 variants, a serine or
valine occurs instead of arginine (R311) in T. cruzi TS.
Interestingly, similar differences occur also in T. brucei
TS (Figure 2). Since these amino acids are close to the
active site, they could influence the acceptor binding
specificity. The arginine at position 144 (blue label) is
conserved in all TS, with the exception of T. congolense
TS1g, where it is a cysteine.
In Figure 4B the amino acid positions are highlighted,
which have different side chains in TS1a-TS1j (Figure
3). It should be noted that these are all on the same
side of the protein as the catalytic site. Striking is a clus-
ter of amino acid variations in the lectin domain (posi-
tion 599 to 602 and 643) suggesting that these changes
may influence substrate binding of larger substrate
molecules, such as glycoproteins.
Characterization of T. congolense TS1 enzyme activity
All eleven TS1 gene products (TS1a-TS1j) were
expressed as recombinant proteins and were recognized
by the anti- T. congolense TS antibody (mAb 7/23) [6]
(data not shown). For all TS1 variants similar robust TS
activity could be determined, except for TS1g. This var-
iant, which carries cysteine instead of arginine at posi-
tion 144, had only very low TS activity. However, in
contrast to the other variants, TS1g released free Sia
from fetuin at about 50% of the transfer to lactose. Two
of the T. congolense TS1 variants, TS1b and TS1 e-1,
were further characterized. They differ in eleven of the
total 25 positions with amino acid variations listed in
Figure 3, three in the catalytic domain and eight in the
lectin domain.
The donor substrates fetuin 3’SL or pNP-Neu5Ac and
the acceptor substrates lactose, galactose or Gal-MU
were employed to determine sialidase and trans-sialidase
activities. For this purpose, a new assay was established
ATGTGGCCGGTGAATTGTTACGCGCTGCTGGCGCTTGTTGTGGCGGGT CAGTGCTGCGACCACATGCATGCCACTGCCGCTGTGGGAACGACGCACCAGGCGCTGCTATGGGG CTCCAAATGGGCTCTGAGGA
ACAAGACGACCCCGAAAGATGGCGAGGTGTGGTGGAGCAACCCCCAGCCGGGCTGGAAGGAGGTGTACGACGATGAGTGGGAGGAGTGGTTTA TGGAGCAGGAGGGA CCAACGGGTGTGAATGGTGTGCGGGG
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CAT CCGAAGAACCTTAAGGG CTCGTATTATCGTGATCGCCTGCAGATGTGGATGACGGA CGGCAATCGTATGTGGCATGTCGGG CAGGT CTCTGAGGG CGACGACAACAGTGCCTACAGCT CCCTGCTG TACA
CTCCGGA CGGGGT CCTGTACTGCTTGCATGAGCAGAACATTGATGAGGTGTACAGCCTCCACCTTG TGCGCCTTGTGGA CGAGCTGAAAAGCATTAAATCAACGGCTCTGGTGTGGAAGGCACAGGACGAGCT
T CT CCTGGGCAACTGCCTCCCGGG CGATAAATATGATCCCGGGTGTGACGGCATCCCCACCGCTGGGCTTGCCGGGCTGCTGGTAGGACCCCTGACGGAGAAGACGTGGCCCGACGCGTATCGGTGCGTGAAC
GCTGCAACCAGCGGCGCTGTGAGCACTGCTGAAGGCGTGCGGCTCGACGTGGGTGGCGGTGGCCATGTTGTGTGGCCCGTGAGTGAGCAGGGG CAGGA CCAGCGGTATTACTTTACCAACAGCGAGTTC AC GC
TC GCCGTC ACGGTGCGGTTTG ACGAGATGCCACAGGGGGA GCTCCCGTTGCTGGGGTTTG TG AACC GCGAAGGGAAGGTGAAGAAGATACTGAAGGTGTCGCTG AGCGGGGT GGAGTGGCTCCTGGCATACGG
GAATGAGTACAACAGCACAGCCGCTGAGCCGCTGGA CGTGAACGAGAGCCACCAGGTGGTGCTAGCGCTTCACGACGGGAT CGTCTCCCTGCACGTTGACGGGGGTAACACGACGGCGACTGTGAGCGTGCGC
GTGGCGAGCCCTGCGGAGCTGCTGAACATT CATCAT CT CTTCGTTGGCACCCCAGTTGATGGAGGCGCCAAGGAGCACGCCAACATCACAGTGAGCAATGTCCTGGTGTACAATCGACCGCTGCGTGGCGTGG
AGCTGCTTGGGCTATT CGCGAACAGGGGACGGATTCGTGTGCCTGGGAGCGACAACGGTGTCCT CAGTGGCGGGTGTCTGTCCCTCTGTTAT CT CCTGCTGCTCGTGCATGTGCTGATGTTT
MW PVNCYALLALVVAGQCCDHM H ATAAVGTTHQALLW G SKW A LR
NKTTPKDGEV W W SNPQ PGW K EV YDDEW EEWFMEQEGPTGVN GVRG
EWYRRMKDGYI L VGGPKLNSPD M N STGTTMRTVHSYRIPS I V EV
GGVLMCVGDARYITS TD YFFT D TVAAYST DGGRTW KREV I I PNG
RVDAHYSRVVDPTVVAKGNNIYVLVGRYNVTRGYWHNKNNRAGVA
DW EPFVYKGTVNVGTKDNATDVSISWERTALKSLYNFPVSGSPG
TQ FL GGAGGGVVTSN G TI V LP VQARNKANRVVS M ILYSA DDGKS
W H FGKGEAGVGTSEAALTEWDGKLLISARSDGGQGYRMI F ESSDL
GATWKEML NSI S RVI G NSPGRSGPGSSS GFI T VTVEGVPVMLLT
HPKNLKGSYYRDRLQMW MTDGNRMW HVGQVSE GDD NSAYSS LLY
TPDGVLYCLHEQNIDEVYSLHLVRLVDELKSIKSTALVW K AQDEL
LLG NCLP GDKYDPGC DGI P TA G LAGLLV GPLTEK TW PDAYRC VN
AATSGAVSTAEGVRLDVGGGGHVVWPVSEQGQDQRYYFTNSEFT
LA VTVRFDEM PQGELP LLG FV N REG KVKK I L KVSL SG VE W LLA YG
NEYNST AAEP LD VNES HQVVLALHDGIVS LH VDG GNTTA TV SV R
VASPAELLN IHHLFVGTPVDGGAKEHANITVSNVLVY NRPLRGV
ELLGLFANRG RIRVPGSDNGVLSGGCLS LC YLLLL VHVLM F
1 10 20 30 40 50 60 70 80 90 100 110 120 130
140 150 160 170 180 190 200 210 220 230 240 250 260
270 280 290 300 310 320 330 340 350 360 370 380 390
400 410 420 430 440 450 460 470 480 490 500 510 520 530
540 550 560 570 580 590 600 610 620 630 640 650 660
670 680 690 700 710 720 730 740 750 760 770 780 790
800 810 820 830 840 850 860 870 880 890 900 910 920 930
940 950 960 970 980 990 1,000 1,010 1,020 1,030 1,040 1,050 1,060
1,070 1,080 1,090 1,100 1,110 1,120 1,130 1,140 1,150 1,160 1,170 1,180 1,190
1,200 1,210 1,220 1,230 1,240 1,250 1,260 1,270 1,280 1,290 1,300 1,310 1,320 1,330
1,340 1,350 1,360 1,370 1,380 1,390 1,400 1,410 1,420 1,430 1,440 1,450 1,460
1,470 1,480 1,490 1,500 1,510 1,520 1,530 1,540 1,550 1,560 1,570 1,580 1,590
1,600 1,610 1,620 1,630 1,640 1,650 1,660 1,670 1,680 1,690 1,700 1,710 1,720
1,730 1,740 1,750 1,760 1,770 1,780 1,790 1,800 1,810 1,820 1,830 1,840 1,850 1,860
1,870 1,880 1,890 1,900 1,910 1,920 1,930 1,940 1,950 1,960 1,970 1,980 1,990
2,000 2,010 2,020 2,030 2,040 2,050 2,060 2,070 2,080 2,090 2,100 2,110 2,120
2,130 2,140 2,150 2,160 2,170 2,180 2,190 2,200 2,210 2,220 2,230 2,240 2,250
Figure 1 Primary sequence of TS1a. The full length coding domain sequence [EMBL: HE583283] with corresponding amino acid translations is
shown. The recombinant protein was generated without the N-terminal signal peptide and without the C-terminal region predicted to be
replaced by a GPI anchor in the native protein (framed boxes). Predicted N-glycosylation sites are highlighted by light grey boxes.
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T. congolense TS1e   --------MWPVNCYALLALVVAGQCCDHMHATAAVGTTHQALLWGSKWALRNKTTPKDG
       T. cruzi TS   ------------------------------------------------------------
      T. brucei TS   -MEELHQQMHMPISRLLLIFTAVCHCCALTSKAAGKGTTREAFLSGGSWALRKKLSEKDG
     T. rangeli SA   ------------------------------------------------------------
T. congolense TS1e   EVWWSNPQPGWKEVYDDEWEEWFMEQEGPTGVNGVRGEWYRRMTDGYILVGGPKLNSPDM
       T. cruzi TS   ---------------------------ASLAPGSSRVELFKRQSSKVPFEK---------
      T. brucei TS   EVWWWQDGPNWKDKYDKEWERWFKEEKGPWGGSEKRSEWFARMTGGYITLGKTKILSSAI
     T. rangeli SA   ----------------------------MLAPGSSRVELFKRQSSKVPFEK---------
T. congolense TS1e   NSTGTTMRTVHSYRIPSIVEVGGVLMCVGDARYITSTDYFFTDTVAAYSTDGGRTWKREV
       T. cruzi TS   -DGKVTERVVHSFRLPALVNVDGVMVAIADARYETSFDNSLIDTVAKYSVDDGETWETQI
      T. brucei TS   EGSDKVERTVHSFRIPSFVEVDGVLMGIGDARYLTSTDYFFTDTVAKYSADGGKTWKTEA
     T. rangeli SA   -DGKVTERVVHSFRLPALVNVDGVMVAIADARYETSNDNSLIDTVAKYSVDDGETWETQI
T. congolense TS1e   IIPNGRVDAHYSRVVDPTVVAKGNNIYVLVGRYNVTRGYWHNKNNRAGVADWEPFVYKGT
       T. cruzi TS   AIKNSRA-SSVSRVVDPTVIVKGNKLYVLVGSYNSSRSYWT---SHGDARDWDILLAVGE
      T. brucei TS   IIENGRVDPTYSRVVDPTVVAKADSVFVLVARYNVTKGYWHNENNAAGIADWEPFVYKGV
     T. rangeli SA   AIKNSRA-SSVSRVVDPTVIVKGNKLYVLVGSYNSSRSYWT---SHGDARDWDILLAVGE
T. congolense TS1e   VNVGTKDNATDVSISW-ERTALKSLYNFPVSGSPGTQFLGGAGGGVVTSNGTIVLPVQAR
       T. cruzi TS   VTKSTAGGKITASIKWGSPVSLKEFFPAEMEGMHTNQFLGGAGVAIVASNGNLVYPVQVT
      T. brucei TS   VTKGADGKTSDVRISW-TKTPLKPLYDFTVAGSKGTQFIGGAGNGVVTLNGTILFPVQAR
     T. rangeli SA   VTKSTAGGKITASIKWGSPVSLKEFFPAEMEGMHTNQFLGGAGVAIVASNGNLVYPVQVT
T. congolense TS1e   NKANRVVSMILYSADDGKSWHFGKGEAGVGTSEAALTEWDGKLLISARSDGG-----QGY
       T. cruzi TS   NKKKQVFSKIFYSEDEGKTWKFGKGRSAFGCSEPVALEWEGKLIINTRVD-------YRR
      T. brucei TS   NEDNAVVSMVMYSVDDGVSWHFARGETALLTSEASLTEWNGKLLMSARTDTSGVNVEGGF
     T. rangeli SA   NKKKQVFSKIFYSEDEGKTWKFGKGRSAFGCSEPVALEWEGKLIINTRVD-------YRR
T. congolense TS1e   RMIFESSDLGATWKEMLNSISRVIGNSPGRSGP-------GSSSGFITVTVEGVPVMLLT
       T. cruzi TS   RLVYESSDMGNTWLEAVGTLSRVWGPSPKSNQP-------GSQSSFTAVTIEGMRVMLFT
      T. brucei TS   RKVLESSNLGATWEESLGTISRVIGNSPDRTKPSPTANYPGSSGALITVTLGDVPVMLIT
     T. rangeli SA   RLVYESSDMGNSWLEAVGTLSRVWG-------PSPKSNQPGSQSSFTAVTIEGMRVMLFT
T. congolense TS1e   HPKNFKGSYYRDRLQMWMTDGNRMWHVGQVSEGDDNSAYSSLLYTPDGVLYCLHEQNIDE
       T. cruzi TS   HPLNFKGRWLRDRLNLWLTDNQRIYNVGQVSIGDENSAYSSVLYK-DDKLYCLHEINSNE
      T. brucei TS   HPKNTKGAWSRDRLQLWMTDGNRMWLVGQISEGDDNSAYSSLLLARDGLLYCLHEQNIDE
     T. rangeli SA   HPLNFKGRWLRDRLNLWLTDNQRIYNVGQVSIGDENSAYSSVLYK-DDKLYCLHEINSNE
T. congolense TS1e   VYSLHLVRLVDELKSIKSTALVWKAQDELLLGNCLPGD----KYDPGC-DGIPTAGLAGL
       T. cruzi TS   VYSLVFARLVGELRIIKSVLQSWKNWDSHLSSICTPADPAASSSERGCGPAVTTVGLVGF
      T. brucei TS   VYSLHLVHLVDELEKVNATVRKWKAQDALLAGLCSSSR---KKNDPTCS-GVPTDGLVGL
     T. rangeli SA   VYSLVFARLVGELRIIKSVLQSWKNWDSHLSSICTPADPAASSSERGCGPAVTTVGLVGF
T. congolense TS1e   LVGPLTEKTWPDAYRCVNAATSGAVSTAEGVRLDVGGGGHVVWPVSEQGQDQRYYFTNSE
       T. cruzi TS   LSHSATKTEWEDAYRCVNASTANAERVPNGLKF-AGVGGGALWPVSQQGQNQRYHFANHA
      T. brucei TS   LAGPVGASVWADVYDCVNASISDGVKVSEGVQLGGKRNSPLLWPVSEQGQDQRYYFANTH
     T. rangeli SA   LSHSATKTEWEDAYRCVNASTANAERVPNGLKFA-GVGGGALWPVSQQGQNQRYRFANHA
T. congolense TS1e   FTLAVTVRFDEMPHGELPLLGFVNRKDQVKKILKVSLSG-VEWLLAYGNEYNSTAAEPLN
       T. cruzi TS   FTLVASVTIHEVPKGASPLLGASLDSSGGKKLLGLSYDKRHQWQPIYGSTPVTPT-GSWE
      T. brucei TS   FTLLATVRFAGEPKAEAPLMGFSNAEGKTSETLSLTVGGK-KWVLTYGSVRKEGPTTSMD
     T. rangeli SA   FTVVASVTIHEVPSVASPLLGASLDSSGGKKLLGLSYDERHQWQPIYGSTPVTPTGSWE-
T. congolense TS1e   VNESHQVVLTLHDGIVSLHVDGGNMTATVSVRVASPAELLNIHHLFVGTPVDGGAKEHAN
       T. cruzi TS   MGKRYHVVLTMANKIGSVYIDGEPLEGSGQ-TVVPDERTPDISHFYVGGYKRSGMPTDSR
      T. brucei TS   WNQTHQIALTLRDGKVDAHANGELIIKEVSVGASESSAHLHLSHFFIGAPVNDSGEGGNN
     T. rangeli SA   MGKRYHVVLTMANKIGSEYIDGEPLEGSGQ-TVVPDERTPDISHFYVGGYKRSDMPTISH
T. congolense TS1e   ITVSNVLVYNRPLRGVELLGLFANRGRIRVPGSDNSVLSGGCLSLCYLLLLVHVLMF-
       T. cruzi TS   VTVNNVLLYNRQLNAEEIRTLFLSQDLIGTEAHMD-----------------------
      T. brucei TS   VIVRNVLLYNRKLDEDELQVLYSNREKIQPVVSAVGIPEGMSAPRLCCLLILMYVLAI
     T. rangeli SA   VTVNNVLLYNRQLNAEEIRTLFLSQDLIGTEAHMDSSSDTSA----------------
S GSW
HA HAN
YID
HG HG
KG
LN L
WE
LT LTL NM NMT
RKDQ NRKDQ
LDSSG
                          180       190       200       210       220       230
                          240       250       260       270       280       290
  400       410       420       430        440      450
  460       470       480       490           500        510
  520       530       540       550       560       570
  580       590       600       610        620       630
  640       650       660       670       680       690
  700       710       720       730       740       750 
                          300       310       320       330       340
350       360       370              380       390
E E G RGE T MTD
R R
V TV
R RE
A A
GV AGVA NR NNRA K NKN
S SK
A A K NKA
G GRS RS
L TL
Y YR Y S S G F FK
Figure 2 Primary sequence alignment of trypanosomal trans-sialidases. The amino acid sequence of T. congolense [EMBL: HE583287] TS1 e-
1 was aligned with T. cruzi TS [EMBL: BAA09334.1, PDB: 3B69], T. brucei TS [EMBL: AAG32055.1] and T. rangeli SA [EMBL: AAC95493.1] based on a
structural alignment of T. congolense TS1 e-1 with T. cruzi TS generated with Yasara during homology modeling. Amino acids, which have been
proposed to be relevant for enzymatic activity are marked with black frames if conserved or with black frames and light grey background if not
conserved. Positions with variations occurring in T. congolense TS1 or T. brucei TS [3] are highlighted by dark grey boxes.
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Page 4 of 16as described under Methods, using HPAEC-PAD to
quantify sialylated oligosaccharide products with the
detection limit of 20 pmol 3’SL corresponding to 0.5
μM in the reaction mixture. In standard assays, 50 μL
TS reactions were set up with 50 ng TS1b or TS1 e-1,
100 μg fetuin (approx. 600 μM bound Sia) as donor sub-
strate and 100 nmol acceptor substrate (2 mM e. g. lac-
tose or galactose). Under these conditions, linear
product formation was obtained for up to 2500 pmol
corresponding to 50 μM3 ’SL (Figure 5).
If lactose is used as a donor substrate under standard
conditions, 3’SL concentration increases linearly for
about 30 minutes before the reaction velocity started to
decrease (Figure 5A). It should be noted that lactose
was sialylated almost twice as fast by TS1b than by TS1
e-1. In contrast to lactose, galactose was sialylated at the
same rate by both enzymes, but at about 20-fold lower
velocity than lactose.
Different specific activities were obtained for T. congo-
lense TS1b, TS1 e-1 and T. cruzi TS (Figure 6). The
reaction velocity was linearly dependent on the amount
of TS as long as the concentration of the product 3’SL
was below 50 μM. Under standard conditions 50 μM
3’SL was produced in 30 minutes with 50 ng TS. If 200
ng TS or more were used, product formation was inde-
pendent of the amount of TS, probably due to the
increased use of 3’SL as a donor substrate in the reverse
reaction, finally leading to an equilibrium between lac-
tose, 3’SL, sialylated and desialylated glycans on fetuin.
This equilibrium apparently was reached in 30 minutes
w i t h5 0 0n gT S( 2 6 6±4μM3 ’SL for T. cruzi TS, 194
±6μM3 ’SL for TS1b and 165 ± 7 μM3 ’SL for TS1 e-
1). After 20 h incubation, 50 ng TS was sufficient to
reach the equilibrium. Independent of the amount of
enzyme used, for all three TS applied similar final con-
centrations of 3’SL were obtained after 20 h incubation
(Table 1).
The HPAEC-PAD method used allowed not only
determining the TS, but also SA activity, since free Sia
and 3’ SL could be quantified from the same chromato-
gram. In standard reactions (50 ng TS, 30 min incuba-
tion time) no SA activity could be detected, both in the
presence or absence of lactose as an acceptor substrate.
This suggests that these TS1 variants usually need an
acceptor substrate like lactose to cleave Sia from a
donor substrate. However, after 20 h incubation, free Sia
was detected. The quantity of Sia released was depen-
dent on the amount of TS used (Table 1). Besides stan-
dard TS reactions with fetuin as donor and lactose as
acceptor substrate, TS reactions with 2 mM 3’SL as
donor and 2 mg/mL ASF as acceptor substrate were
performed. In these reactions, free Sia was detected after
short reaction times and after incubation for 24 h, 0.5-1
mM free Sia were produced (data not shown).
position TS1a TS1b TS1c TS1d TS1e TS1e' TS1f TS1g TS1h TS1i TS1j
79 E K EEEEEEEEE
89 GTGGGGGGAGG
96 KKTTTTKKKKT
144 RRRRRRRCRRR
170 RRRSRRSRRRR
215 KKRQKKQKKQQ
217 NNDDNNDNNDD
218 RRKERRERREE
220 GGAGGGAGGGG
221 VVIVVVIVVVV
293 KKKKKKKKKKN
338 AAAAAATAAAA
375 GGK GGGPKKKS
377 SSNSSSSNNNS
404 LLLLFLLLLLL
407 SSSVSSSSSSS
409 YYYSYYYYYYY
588 QQQQHHHQRRR
599 RRRRRRRHHRR
600 EEEEKKKKKKK
601 GGGGDDDGGGG
602 KKKKQQQKKKK
633 DDDDNNNNLDD
643 AAAATTTTAAA
658 TTTTM M MTTMT
Catalytic domain
Lectin domain
Figure 3 Amino acid variations found in T. congolense TS1a-
TS1j. TS1a [EMBL: HE583283], TS1b [EMBL: HE583284], TS1c [EMBL:
HE583285], TS1d [EMBL: HE583286], TS1 e-1 [EMBL: HE583287] , TS1
e-2 [EMBL: HE583288], TS1f [EMBL: HE583289], TS1g [EMBL:
HE583290], TS1h [EMBL: HE583291], TS1i [EMBL: HE583292], TS1j
[EMBL: HE583293]. Differences in amino acids are highlighted (light
grey: conservative; dark grey: modest; black: drastic change).
Figure 4 Homology model of T. congolense TS1. The crystal
structure of T. cruzi TS [12] in complex with 3-fluoro-5-N-acetyl-9-
benzamido-2,9-dideoxy-neuraminic acid was used as template to
calculate a model structure for T. congolense TS1 e-1. Only the
Neu5Ac part (orange) of the ligand in the binding site of the
complex is illustrated. (A) Conserved amino acids of the active site
are labeled in white. Amino acids at positions reported to be
important for ligand binding in T. cruzi TS [12], which are not
conserved in T. congolense are labeled in yellow. The red labeled
position 407 is a serine or valine in T. congolense TS1 forms. R144,
which is exchanged to a cysteine in TS1g, is labeled in blue. (B)
Green clouds mark positions at which different amino acids occur in
other T. congolense TS1 forms.
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Page 5 of 16For kinetic experiments, assays were incubated for 30
minutes using 50 ng TS, since under these conditions
3’SL production was linear for all three TS. To deter-
mine the kinetic parameters for the acceptor substrates
lactose (Figure 7A) or Gal-MU (Figure 7C), 100 μg
fetuin (600 μM bound Sia) was used as donor substrate.
The lowest KM for lactose was found for T. cruzi TS
with 327 μMc o m p a r e dt o1 6 8 3μM for TS1b and 727
μM for TS1 e-1 (Table 2). Furthermore, T. cruzi TS was
able to produce twice more 3’SL than TS1b and fourfold
more than TS1 e-1 under these conditions.
To determine the kinetic parameters for the donor
substrate fetuin (Figure 7B), 2 mM lactose was used as
acceptor substrate. Both T. congolense TS1 had similar
vmax-values, whereas the vmax for T. cruzi TS was about
fivefold higher. Different to the KM of lactose, the lowest
KM for fetuin was exhibited by TS1b with 359 μM,
which is about fivefold lower compared to TS1 e-1 with
1617 μM and about 12-fold lower compared to T. cruzi
TS with 4124 μM.
Kinetic studies with TS were also performed for the
acceptor substrate Gal-MU (Table 2) and the donor
substrate pNP-Neu5Ac. Almost similar KM and vmax-
values were found for both T. congolense TS1. The sub-
strate pNP-Neu5Ac was only weakly used as a donor
substrate by all three TS species. Therefore, no reliable
kinetic parameters could be determined.
time (min)
0 20 40 60 80 100 120
3
‘
S
L
 
(
p
m
o
l
)
0
2000
4000
6000
8000
10000
TS1b (lactose)
TS1e (lactose)
time (min)
0 20 40 60 80 100 120
S
i
a
-
G
a
l
 
(
p
m
o
l
)
0
100
200
300
400
500
TS1b (galactose)
TS1e (galactose)
AB
Figure 5 Time dependence of TS reactions. Reactions of 100 μg fetuin with 100 nmol lactose (A) or 100 nmol galactose (B) were started with
50 ng TS in 50 μL and incubated at 37°C. The amount of 3’SL produced was determined by HPAEC-PAD as described under Methods. Data
points are means ± standard deviations of three replicates.
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Figure 6 Concentration dependence of TS reactions.R e a c t i o n s
of 100 μg fetuin with 100 nmol lactose were started with varying
amounts of TS in overall 50 μL 10 mM phosphate buffer, pH 7.4
and incubated at 37°C for 30 min. The amount of 3’SL produced
was determined by HPAEC-PAD as described under Methods. Data
points are means ± standard deviations of three determinations.
Table 1 Free Sia and 3’SL production at equilibrium of
the reaction
Neu5Ac [pmol] 3’SL [pmol]
0n gT S 262 ± 46 0
50 ng T. cruzi TS 580 ± 8 12597 ± 115
250 ng T. cruzi TS 1820 ± 13 11199 ± 288
50 ng TS1b 415 ± 7 15378 ± 117
250 ng TS1b 1095 ± 129 14435 ± 2226
50 ng TS1 e-1 348 ± 83 12719 ± 3057
250 ng TS1 e-1 1186 ± 9 13655 ± 491
only fetuin 116 ± 8 0
Neu5Ac and 3’SL produced by TS after 20 h incubation under standard
conditions were determined as described under Material and Methods. Data
points are means ± standard deviations of three replicates.
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Page 6 of 16Sialylation pattern of glycopeptides
Structural differences between TS1 variants may influ-
ence the enzymes preference for glycans on glycopro-
teins, such as fetuin. This could possibly result in
different sialylation patterns on glycoproteins after incu-
bation with TS. Fetuin contains 3 N-glycosylation sites
and 3 O-glycans, which all can serve as Sia donors in
TS reactions [13]. To investigate the specificity of TS
towards different N-glycans on fetuin, we used MALDI-
TOF-MS to determine the sialylation pattern of glyco-
peptides (GPs) from trypsin-digested fetuin after incuba-
tion with TS and lactose (Figure 8).
The sialylation patterns of three glycopeptides, GP
127-141 (dibranched or tribranched), and GP 54-85
(tribranched) were determined. All 14 potential sialyla-
tion variants of these glycopeptides could be identified
unambiguously and quantified from the MALDI-TOF-
MS spectra. In untreated fetuin most branches on the
three N-glycans investigated were sialylated, whereas
upon treatment with TS and lactose after 30 minutes a
clear shift towards incompletely sialylated glycans was
observed. After 24 h TS incubation the relative
amounts of unsialylated glycans was further increased
and monosialylated glycans represented the most pro-
minent species on both, di- and tribranched glycans
(Figure 9).
Sialylation of glycoproteins
As described above, T. congolense TS1b and TS1 e-1
readily used fetuin as donor substrate for the production
of 3’SL. However, long-term TS reactions or experi-
ments with higher amounts of TS had suggested that
the reverse reaction also takes place. Therefore, we
investigated whether T. congolense TS1b and TS1 e-1
can restore sialylated glycans on Vibrio cholerae siali-
dase-treated fetuin (ASF) as model glycoprotein. Resialy-
lation experiments were performed with 100 μgA S Fa s
acceptor and 100 nmol 3’SL as donor substrate as well
as 50 ng TS1 in 50 μL to start the TS reaction and were
incubated up to 24 h. This resialylation partially
reversed the shift in electrophoretic mobility in SDS-
PAGE observed for sialidase-treated fetuin (Figure 10).
Also by MALDI-MS of glycopeptides, the sialylation of
unsialylated glycans was confirmed (data not shown).
Furthermore, we addressed the question of whether
through this reaction recognition sites for siglecs can be
restored. For this purpose, TS-treated ASF was immobi-
lized to a microtitre plate and used as target for Siglec-
4, which preferentially binds a2,3-linked Sia. Under
these conditions robust Siglec-4 binding was observed
of ASF that had been treated with TS for 4 h. A pro-
longed (up to 24 h) TS reaction only led to little further
increase reaching 40% of binding levels observed with
native fetuin (Figure 11).
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Figure 7 Michaelis-Menten kinetics of TS reactions. All reactions
were started with 50 ng TS in a final volume of 50 μL and
incubated for 30 min at 37°C. (A) 600 μM fetuin-bound Sia was
used as donor substrate with varying concentrations of lactose as
acceptor substrate. (B) Varying concentrations of fetuin-bound Sia
were used as donor substrate with 2 mM lactose as acceptor
substrate. (C) Varying amounts Gal-MU were used as acceptor
substrate and 50 nmol 3’SL as donor substrate. The amount of 3’SL
(in the case of (A) and (B))o r3 ’Sia-Gal-MU (in the case of (C))
produced was determined by HPAEC-PAD as described under
Methods. Data points are means ± standard deviations of three
replicates.
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In 2003 Tiralongo et al. published a partial sequence for
T. congolense TS1 [9]. Our approach to obtain the full
length sequence of TS1 led to the discovery of 11 var-
iants of this gene with an overall sequence identity of
96.3% in the genome of this parasite. The previously
published partial TS1 sequence, which had been
assembled from 47 independent PCR reactions, turned
out to represent a mixture of fragments from the 11
TS1 forms identified in this study. Therefore, it is likely
that that sequence doesn’t exist in nature.
Similar TS-like gene families occur also in other trypa-
nosomes. In T. brucei the situation appears to be less
complex, since only 8 TS closely related genes have
been identified [3] and these differences lead to 6 amino
acid mutations. The largest TS gene family has been
found in T. cruzi. Its 140 members fall into three differ-
ent groups [14]. Blood stream trypomastigotes express
two of these groups, one with TS activity and the other
only with lectin activity. A third group has TS activity
and is expressed by epimastigotes. At present it is
unknown whether the expression of the different TS
genes in African trypanosomes is also stage-dependent.
T. congolense TS1 shares about 57% identical amino
acids with T. brucei TS and 48% sequence identity with
T. cruzi TS. By comparison, the American T. rangeli SA
and T. cruzi TS are more closely related with approxi-
mately 70% sequence identity [15].
The homology model for T. congolense TS1 based on
crystal structures from T.cruzi TS and T. rangeli SA
provided (I) insight in differences in the active site and
its surrounding between TS from these parasites and
(II) revealed the spatial distribution of the amino acid
differences between the TS1 variants.
Compared to T. cruzi TS only three amino acids are
changed in TS1 (A325, S407 and Y408). At position 325
ap r o l i n ea tt h ec o r r e s p o n d i n gp o s i t i o no fT. cruzi TS
appears to be relevant for full TS activity [11]. However,
in both, T. brucei TS and in T. congolense TS1, position
325 is an alanine. Tiralongo et al., (2003) postulated
A325 might be common to African trypanosomes and
does not seem to have an effect on enzymatic activity
[9]. Our data have demonstrated that an alanine at this
position is well compatible with TS activity, since all
active TS1 variants have A325. The exchanges at 407
and 408 may be relevant for the different substrate
Table 2 Kinetic parameters of T. cruzi TS, T. congolense TS1b and TS1 e-1
Acceptor substrates Donor substrates
Lactose Gal-MU Fetuin-bound Sia
x
vmax
(μmol/(min × mg TS))
KM
(μM)
vmax
(μmol/(min × mg TS))
KM
(μM)
vmax
(μmol/(min × mg TS))
KM
(μM)
TS1b 4.3 ± 0.1 1683 ± 101 0.77 ± 0.03 57 ± 14 7.9 ± 0.3 359 ± 45
TS1 e-1 2.1 ± 0.1 727 ± 48 0.72 ± 0.03 74 ± 17 7.6 ± 0.5 1617 ± 223
T. cruzi TS 8.4 ± 0.3 327 ± 31 n.d. n.d. 37.9 ± 6.0 4124 ± 985
KM and vmax were calculated from Michaelis-Menten kinetics (Figure 7) by SigmaPlot. Data points are means ± standard deviations of three replicates. ×
Approximately 30 nmol Sia per 100 μg fetuin. Abbr.: n.d.: not determined.
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Figure 8 MALDI-TOF-MS of glycopeptide 127-141 sialylation variants. 100 μg fetuin were treated with trypsin and analyzed by MALDI-TOF-
MS as described under Methods. The symbols code for the monosaccharide units is according to the nomenclature of the Consortium for
Functional Glycomics (http://www.functionalglycomics.org): GlcNAc (blue squares), Man (green circles, Gal (yellow circles), Neu5Ac (purple
diamonds).
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Page 8 of 16specificities of TS species, since this area possibly parti-
cipates in the interaction with the underlying galactose.
With the full length coding sequence of TS1 available,
the enzymes were expressed and characterized as
recombinant proteins to address the question of
whether TS1 accounts for the TS activity in the two
preparations (TS-form 1 and TS-form 2) from procyclic
parasite cultures [6]. The amino acid sequences of the
eleven TS1 variants described here contain the peptide
VVDPTVVAK present in TS-form 1. Furthermore, all
recombinant TS1 variants reacted with the anti-T. con-
golense TS antibody (mAb 7/23) [6]. Based on this
information, it is now clear that TS1 was present in
both, TS-form1 and TS-form 2. However, two
observations made with recombinant TS1 suggest that
the native enzyme preparations of TS-form 1 and even
more for TS-form 2 contained additional TS1-like pro-
teins. (I) The reaction velocities with the synthetic sub-
strates pNP-Neu5Ac (as donor) and Gal-MU (as
acceptor) were much lower than with fetuin and lactose
for all three TS. Tiralongo et al., 2003 [6] determined a
KM of 500 μM for Gal-MU, which is approximately 10-
fold higher than for TS1b (57 μM) and TS1 e-1 (74
μM). These differences could be due to the presence of
other TS1-like enzymes in the preparations of TS-form
1 and TS-form 2. (II) Using the substrate Neu5Ac-MU
no SA or TS activity could be detected for the T. congo-
lense TS1 variants investigated here, whereas cleavage of
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Figure 9 Relative changes of the sialylation pattern of fetuin N-glycans. Shown are the sialylation patterns of the glycopeptides GP 127-141
with dibranched (GP 127-141 di) or tribranched (GP 127-141 tri) glycans and of the glycopeptide GP 54-85 with tribranched glycans (GP 54-85
tri) relative to the non-sialylated GP 1 -32. 100 μg fetuin was incubated with 50 ng TS1b, TS1 e-1 or T. cruzi TS and 100 nmol lactose for the
times indicated, trypsinized and glycopeptides analyzed by MALDI-MS as described under Methods. Data points are averages ± standard
deviations of three to ten replicates.
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Page 9 of 16this substrate indicated SA activity in preparations of
TS-form 1 and TS-form 2 [6], as well as TS activity in
procyclic parasites [16]. Also this apparent discrepancy
can easily be explained by the presence of other TS1-
like enzymes accepting Neu5Ac-MU as TS or SA
substrate.
Ten of the eleven recombinant TS1 variants revealed
TS activity, which is in agreement with the TS-form 1
purified by Tiralongo et al. [6]. Only TS1g, which carries
a cysteine at position 144 instead of an arginine, showed
very low TS but clear SA activity. This suggests that
R144 is important but not essential for the transfer reac-
tion and hinders SA activity in T. congolense TS1. In a
previous study on T. rangeli SA [17] R144 has been pos-
tulated to form a hydrogen bond to the O4 of Sia. How-
ever, it remains unclear how this could relate to TS
activity. Furthermore, the homology model of TS1 does
not provide evidence for such a hydrogen bond for the
binding site of T. congolense TS1.
The TS1 homology model (Figure 4B) displays also
the position of amino acid exchanges in the eleven
TS1 forms identified. It could be speculated that
these positions are relevant determinants of antigenic
sites and that these variations help to escape recogni-
tion by the immune system. However, if TS1 is
expressed in the procyclic form in the insect vector,
this is unlikely to be relevant. Interestingly, these
exchanges are located on the same side of the protein
where substrate binding occurs, which opens the pos-
sibility that these changes influence the binding speci-
ficities. The cluster of changes from position 599 to
602 and 643 could be involved in recognition of lar-
ger substrate molecules, such as glycoproteins. Posi-
tions, 407 and 408 (Figure 4B), as well as positions
375, 377 and 404 (Figure 4A) are closer to the active
site in the catalytic domain, possibly contributing to
interactions with substrates. It should be noted that
the six amino acid differences occurring in T. brucei
TS are not found in clusters like in T. congolense
TS1, and furthermore, they are not even on the same
side of the protein.
For a more detailed characterization of their differ-
ences in activity, we choose two TS1 variants, TS1b and
TS1 e-1. The two amino acid sequences of TS1b and
TS1 e-1 differ mainly in the lectin domain (Figure 4),
whereby the exchange from E600 in TS1b to K600 in
TS1 e-1 represents the most drastic change.
The observation that lactose is a much better acceptor
substrate than Gal is in agreement with previously
reported relative transfer activity data for the prepara-
tions TS-form 1 and TS-form 2 [9]. Interestingly, with
fetuin as donor substrate T. cruzi TS, T. congolense
TS1b and TS1 e-1 produced different amounts of 3’SL
in 30 minutes under identical conditions. It is likely that
these differences are due to distinct substrate specifici-
ties for the sialoglycans of fetuin. However, after 20 h,
equilibriums for the reactions were attained and the
three TS applied produced almost the same amounts of
3’SL. Most likely this reflects a similar equilibrium for
these three TS.
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Figure 10 SDS-PAGE of resialylated fetuin.A S F( 4 5t o5 8k D a ) :
Vibrio cholera sialidase-treated fetuin (58 to 65 kDa). For resialylation
ASF was treated with TS1 e-1 and 3’SL for 24 h. 2 μg protein per
lane were run on a 12% polyacrylamide gel. Abbr.: MW: molecular
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Figure 11 Binding of Siglec-4 to resialylated fetuin. Vibrio
cholera sialidase-treated fetuin (ASF) was treated with TS1 e-1 and
3’-SL for the times indicated as described under Material and
Methods. Siglec-4 binding relative to untreated fetuin is shown.
Data points are means ± standard deviations of three independent
determinations.
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Page 10 of 16Clear differences were found in the kinetic parameters
of TS1b and TS1 e-1 for lactose and fetuin. Reliable
kinetic parameter for 3’SL as donor substrate could not
be determined, because of the inaccurate quantification
of the high concentrations of 3’SL as donor substrate.
Whereas TS1b has a slightly higher KM (1683 μM) for
lactose compared to TS1 e-1 (727 μM), the opposite
and more pronounced difference was observed for
fetuin-bound Sia, where TS1 e-1 has approximately five-
fold higher KM (81 μM) compared to TS1b (17 μM). In
combination, this implies that the ratio of KM for lac-
tose/KM for fetuin-bound Sia is approximately 100 for
TS1b, whereas it is only 10 for TS1 e-1. By comparison,
for T. cruzi TS the KM for both substrates is quite simi-
lar (326 over 206 μM) and its vmax was fourfold higher
than for the TS1 isoforms. The differences in the kinetic
parameters for fetuin observed for TS1b and TS1 e-1
are possibly related to altered affinities resulting from
amino acid divergences in the lectin domain of TS1b
and TS1 e-1. This would suggest a mechanism linking
the lectin domain to the enzymatic properties of TS.
No release of free Sia could be detected after 30 min-
utes of TS reactions with fetuin as donor and lactose as
acceptor substrates, demonstrating the absence of SA
activity. However, after 20 h incubation, free Sia was
detected clearly indicating SA activity. This activity cor-
related with the TS amount present, implying SA activ-
i t yt ob eas i d er e a c t i o no b s e r v a b l eo n l yi ne x t e n d e d
reactions. Interestingly, in the reverse TS reactions with
3’SL as donor substrate for sialylation of galactose resi-
dues of ASF, free Sia is detected very early in the reac-
tion (data not shown). This suggests that the free Sia
detected in extended TS reactions times with fetuin as
donor substrate is mainly the product of a SA side activ-
ity of the reaction using 3’SL as substrate. Therefore, the
amount of free Sia could provide indirect information
on the velocity of the reverse reaction. This assumption
is further supported by the fact that lower amounts of
TS can led to the same amount of final 3’SL but pro-
duce less free Sia as side product (Table 1). In this con-
text it should be noted, that TS from T. cruzi clearly
produced more free Sia than T. congolense TS1b or TS1
e-1. The structural basis for this phenomenon is unclear
but may be related to the kinetics of the reaction. TS
have been reported to follow ping-pong bi bi kinetics
[12,18,19]. It will be interesting to investigate the struc-
ture-function relationship of this phenomenon and
whether this is related to the SA activity of TS1g.
The TS substrate specificities for the glycans of the
donor substrate fetuin were investigated by a MALDI-
TOF analysis of TS treated glycopeptides from trypsin
digested fetuin, since the glycosylation of fetuin is well
established [13,20-23]. Three glycopeptides coming from
two of the three N-glycosylation sites (di- and
tribranched GP 127-141, and tribranched GP 54-85)
could be analyzed reliably. The predicted masses of GP
142-169 di could not be identified in any spectra. GP
54-85 di and GP 142-169 tri differed only in one Da,
which were not resolved by the equipment available and
were excluded from the analysis. The peptide containing
the three O-glycosylation sites could not be detected
due to its high mass. But it is important to note, that
TS1 clearly utilizes sialylated O-glycans as donor sub-
strates as indicated by a rapid unmasking of peanut
agglutinin recognition sites (data not shown).
Only minor differences in the sialylation pattern of
fetuin GPs were observed using the different TS species.
In summary, these were too small to draw a conclusion
that these TS differ in their substrate specificities for
fetuin glycans. In general, the TS applied cleaved Sia
from N-glycans of glycopeptides investigated, but also
transferred Sia back to these N-glycans. N-glycans that
carried three and four Sia molecules in the case of the
tribranched N-glycans as well as N-glycans that carried
two Sia molecules in the case of dibranched N-glycans
before TS incubation, were reduced to predominantly 0-
2 Sia molecules in the case of tribranched and 0-1 Sia
molecule in the case of dibranched N-glycans after 24 h
TS incubation.
Whereas in the reactions discussed above Sia was
transferred from fetuin to synthesize 3’SL, we could also
show that T. congolense TS1 as well as T. cruzi TS
transfer Sia in the reverse direction from 3’SL to glyco-
proteins. Furthermore, the TS reaction restores binding
of Sia-binding proteins, such as Siglec-4. Due to the
reversibility of the reaction, a complete resialylation of
an acceptor substrate applying TS cannot be expected
under these conditions. Nevertheless, differences in the
kinetic parameters as shown for two of the eleven T.
congolense TS1 variants could be used in kinetically con-
trolled reactions to optimize the TS reaction to one or
the other product, making the TS1 variants interesting
tools for biotechnological applications. Thus, TS1 can
be utilized to transfer Sia in a2,3-linkage on biologically
relevant glycoproteins containing terminal galactose as
Sia acceptor.
Conclusions
For the first time, full length TS from the African para-
site T. congolense has been cloned and sequenced, open-
ing new perspectives for investigations on the biological
r o l eo ft h e s ee n z y m e si nt h ep u r s u i to fac u r ef o r
Nagana and sleeping sickness. Eleven T. congolense TS1
variants were identified and expressed as recombinant
proteins. The eleven TS1 differ in 25 of 702 amino acid
positions and a structural model revealed that these var-
iations occur in three clusters on the side of the protein
that is open to substrate binding. Ten of these TS1
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Only one, TS1g, has much lower TS but increased SA
activity, probably due to an exchange of an arginine to
a cysteine at position 144. Interestingly, the kinetic
parameters of two characterized TS1 variants reveal
subtle differences in substrate specificities. However,
these did not lead to major differences in the sialylation
pattern of N-glycans on fetuin after treatment with dif-
ferent TS variants. Finally a proof of principle has been
provided that these TS can be used to sialylate glyco-
conjugates to create binding sites for Sia-binding pro-
teins like Siglec-4.
It will be interesting to investigate the expression pat-
terns of TS1 variants in the parasite’s life cycle in future
investigations addressing their importance for the mani-
festation of midgut colonization and maturation in the
tsetse vector with possible implications for the transmis-
sion to the mammalian host.
Methods
Materials
Complete Mini, EDTA free protease-inhibitor tablets
and Vibrio cholerae sialidase were purchased from
Roche Diagnostics, Mannheim, Germany. Pfu DNA
polymerase and restriction enzymes BamHI and SpeI,
isopropyl b-D-1-thiogalacto-pyranoside (IPTG), Page-
Blue and molecular weight marker (PageRuler) were
from Fermentas, St. Leon-Rot, Germany. Trypsin was
from Promega, Mannheim, Germany, 2,5-Dihydroxyben-
zoic acid from Bruker Daltonics, Billerica, USA. Ultrafil-
tration units Vivaspin6 and VivaCell250 were from
Sartorius, Göttingen, Germany. BCA Protein Assay Kit
was purchased from Thermo Scientific Pierce, Rockford,
USA. Anti-SNAP-tag rabbit polyclonal antibody was
from GenScript, Piscataway, USA. Anti-Strep-tag rabbit
polyclonal antibody, StrepTactin beads and buffers were
purchased from IBA, Göttingen, Germany and hygromy-
cin from PAA, Pasching, Austria. 2’-(4-Methylumbelli-
feryl)-a-D-N-acetylneuraminic acid sodium salt hydrate
(MU-Neu5Ac), 4-methylumbelliferyl ß-D-galactoside
(MU-Gal), 4-methylumbelliferone (MU), glucoronic
acid, Ex-cell
® CD CHO media, fetuin and PEI transfec-
tion reagent were purchased from Sigma-Aldrich,
Munich, Germany. X-ray film, enhanced chemilumines-
cence system, Ni-NTA and Q-Sepharose FF were pur-
chased from GE Healthcare, Munich, polyvinylidene
difluoride membranes and ZipTips from Millipore,
Schwalbach, Germany.
Cloning and expression of recombinant TS1
The published partial sequences of Trypanosoma congo-
lense TS1 [Genebank: AJ535487.1] [6,9] was used as
starting query for searching the T. congolense genomic
database for pathogen genomics at the WTSI (http://
www.sanger.ac.uk/). Based on the obtained sequence
fragments, an open reading frame encoding TS1 was
assembled. Based on this, primers were designed to
amplify TS1 from T. congolense (strain STIB 249) geno-
mic DNA [9] using Pfu DNA polymerase in a nested
PCR reaction leaving out the N-terminal signal peptide
sequence and the C-terminal GPI anchor attachment
site. Both outside primers (forward ATG CGG CCG
GTG AAT TGT TAN and reverse CAT CAG CAC
ATG CAC GAG CAN) were degenerate at the 3’ end,
whereas the internal primers (forward CGA CTA GTC
AGT GCT GCG ACC ACA TGC AN and reverse CGG
GAT CCG TCG CTC CCA GGC ACA CGA AN) were
designed to introduce Spe1a n dBamHI restriction sites,
respectively. These restriction sites were used to ligate
the PCR-products in frame into a modified pDEF [24]
vector (pDEF-T3C/SNAPstrep) providing in frame a
Transin cleavable signal peptide [25], a 3C-protease
cleavage site [26] followed by SNAP (Covalys, Witters-
wil, Switzerland) and Strep (IBA, Göttingen, Germany)
tags. The pDEF-T3C/SNAPstrep was obtained as fol-
lows: The coding sequence for the Transin signal pep-
tide has been introduced into pcDNA 3 Amp Strep-tag
[27] using the HindIII/BamHI-digested linker obtained
by hybridization of the following oligonucleotides: sense
5’-CGAAGCTTATGAAAGGGCTCCCAGTCCTGC
TGTGGCTGTGTACGGCTGTGTGCTC
ATCCTACCCATTGCATGGCAGTGAAGAAGAT
GCTGGCATGGAGACTAGTGGATCCCG
and antisense primer 5’-
CGGGATCCACTAGTCTCCATGCCAGCATCTT
CTTCACTGCCATGCAATGGGTAGG
ATGAGCACACACAGCCGTACACAGCCACAGCA
GGACTGGGAGCCCTTTCATAAGCTTCG.
This Transin linker introduced a unique SpeIr e s t r i c -
tion site. The coding sequence of the hAGT protein
(SNAP) was amplified using the pSNAP-tag
® (T7) vec-
tor (NEB, Ipswich, MA, USA) as a template and sub-
cloned in frame into BamHI/EcoRI digested pcDNA3
Amp Transin Strep-tag providing pcDNA3-T3C/SNAP-
strep. The primers used for amplification were: sense 5’-
CGGGATCCCTGGAGGTGCTGTTCCAGGGCCC-
CATGGACAAAGACTGCGAAATGAAGCG-3’ includ-
ing the coding sequence for the 3C protease recognition
site of the human rhinovirus HRV 3C (LEVLFQGP,
underlined) and antisense 5’- CGGAATTCACCCAGC
CCAGGCTTGCCCAGA.
CHOLec1 cells were used for TS1 expression due to
their ability to express only high-mannose glycans, since
these cells are lacking N-acetyl glucosaminyltransferase I
[28]. Transfection of CHOLec1 cells grown in aMEM
supplemented with 10% fetal calf serum at 37°C, 5%
CO2 was accomplished with polyethylenimine (PEI)
transfection reagent following the manufacturer’s
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into 96-well plates in a selection media of aMEM con-
taining varying amounts of hygromycin, ranging from
400 μg/mL to 1000 μg/mL. Expression of recombinant
T S 1( 1 2 0k D ai n c l u d i n gS N A Pa n dStrep tags) was
tested by analyzing cell culture supernatant using Wes-
tern blots with anti TS1 monoclonal antibody (mAb 7/
23) as primary antibody [9]. The presence of SNAP and
Strep tags was confirmed using anti-SNAP-tag rabbit
polyclonal antibody and anti-Strep-tag rabbit polyclonal
antibody respectively in Western blots analysis. Selected
cells were then adapted to Ex-cell
® CD CHO media
supplemented with 8 mM L-glutamine.
Purification of Trypanosoma congolense trans-sialidase
The harvested tissue culture supernatant was supple-
mented with 10 mM Tris/HCl, pH 7.5, 1 mM EDTA, 1
mM DTT and 0.02% sodium azide (all final concentra-
tions) and centrifuged at 125,000 × g for 1 h. The
cleared supernatant was then concentrated 100-fold by
ultrafiltration (100 kDa cut off). Buffer was exchanged
twice using 250 mL 100 mM Tris-Cl, pH 8.0, 150 mM
NaCl, 1 mM EDTA (buffer A) in the same ultrafiltration
unit and concentrated to a total volume of 10 mL for 1
L tissue culture supernatant. This was further clarified
by centrifugation at 21,000 × g for 30 minutes before
applying on a column of 1 mL StrepTactin
® beads equi-
librated with buffer A. After loading the column was
washed with 5 column volumes wash buffer (100 mM
Tris-Cl, pH 8.0, 150 mM NaCl, 1 mM EDTA) and TS1
was eluted with 3 column volumes of elution buffer
(100 mM Tris-Cl, pH 8.0, 150 mM NaCl, 1 mM EDTA,
2.5 mM desthiobiotin) in fractions of 0.5 mL. The affi-
nity purified TS1 was dialyzed (10 kDa cut off) against
10 mM phosphate, pH 7.4. Purification products were
analyzed by SDS-PAGE and quantified by BCA assay
with bovine serum albumin as standard.
Expression and purification of Trypanosoma cruzi trans-
sialidase
Recombinant T. cruzi TS was produced in E. coli M15
(pREP4) according to Agusti et al., 2004 and Neubacher
et al., 2005 [29,30]. In brief, cells were grown in 1 L
“terrific broth” medium overnight at 18°C. Protein
expression was initiated with 0.5 mM IPTG. The cells
were dissolved in 40 mL lysis buffer (50 mM phosphate,
300 mM NaCl, pH 8.0 and 0.05% Lubrol), 1 tablet pro-
tease-inhibitor (Complete Mini, EDTA free) and 1 spa-
tula tip of lysozyme were before incubation of 30
minutes at 4°C. The cells were disrupted by 5 cycles of
sonification on ice. Cells debris was removed by centri-
fugation at 40,000 × g for 60 minutes at 4°C and the
supernatant was filtered using a 0.2 μm pore size filter.
20 mM imidazol was added before application on 0.5
mL Ni-NTA beads. Target proteins were eluted in the
same buffer and 250 mM imidazole. The eluted protein
was dialyzed against 20 mM Tris, 30 mM NaCl, pH 8.0
and further purified using a Q-Sepharose FF column in
the same buffer with a linear gradient up to 1 M NaCl.
The activity of the purified protein was tested by a siali-
dase activity assay using MU-Neu5Ac as donor substrate
and lactose as acceptor substrate as described below.
Vibrio cholerae sialidase treatment of fetuin
Asialofetuin (ASF) was prepared from fetuin by Vibrio
cholerae sialidase (VCS) treatment as described [31]. In
brief, fetuin was digested with VCS in 50 mM sodium
acetate, 9 mM CaCl2, pH 5.5 overnight at 37°C in a dia-
lysis bag against the same buffer and afterwards against
distilled water. Sialylated fetuin and sialidase was sepa-
rated from ASF by anion exchange chromatography
using Q-Sepharose. The proteins were eluted by a linear
gradient from 0 to 1 M NaCl in 10 mM Tris, pH 7.4.
Collected fractions were assayed for protein at 280 nm
and for SA activity with MU-Neu5Ac acid as substrate
as described below. The fractions containing ASF but
no SA activity were pooled and the buffer was
exchanged against 10 mM phosphate, pH 7.4 using
VivaSpin6 ultrafiltration units (10 kDa cut off).
Sialidase activity assay
Sialidase activity (+/- lactose) was determined by apply-
ing a microtitre plate assay detecting free 4-methylum-
belliferone (MU) released from Neu5Ac-MU [6]. In
brief, 50 μL sample were incubated with 1 mM
Neu5Ac-MU (final concentration) in a black 96-well
microtitre plate. To determine T. cruzi TS 1 mM lactose
was added as acceptor substrate. The plate was centri-
fuged for 1 minute at 1,000 × g and incubated for 30
minutes at room temperature in the dark. The reactions
were stopped with 200 μL 100 mM glycine, pH 10 and
the fluorescence intensities were measured at 355 nm
excitation and 460 nm emission using a fluorimeter
(Ascent Fluoroscan).
Trans-sialidase reactions
The principle of this assay is based on the quantification
of sialylated oligosaccharides by high performance
anion-exchange chromatography with pulsed ampero-
metric detection (HPAEC-PAD) as described below. In
these reactions either fetuin is used as donor substrate,
e.g. lactose as acceptor or 3’-sialyllactose (3’SL) is used
as donor substrate with ASF as acceptor. A final volume
of 50 μL 10 mM phosphate buffer were used for all TS
reactions. Stock solutions of donor and acceptor sub-
strate were mixed in 40 μL buffer (10 mM Tris/HCl, pH
7.5) and the reactions were started with 10 μLT S( 5 0
ng in standard reactions) and incubated at 37°C. The
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containing 28 μM glucuronic acid and incubated over-
night at -20°C. After centrifugation for 15 minutes at
20,000 × g and 4°C, 225 μL supernatant were removed
and both, protein pellets and supernatants were
lyophilized.
The dried supernatant of the acetone precipitation was
dissolved in 125 μLH 2Of o rH P A E C - P A D ,w h i c hw a s
carried out by using a DX600 system (Dionex, Sunny-
vale, CA, USA) with an electrochemical detector (ED50),
a gradient pump (GP50) and an autosampler (AS50).
Carbohydrates were separated by HPAEC on a Carbo-
PAC PA1 (4 × 250 mm) analytical column (Dionex)
together with a guard column (4 × 50 mm) using a con-
stant flow rate of 1 mL/min. Sample volumes of 25 μL
were injected and the chromatography was performed
as follows: 100 mM NaOH for 2 min, followed by 100
mM NaOH/100 mM NaOAc for 22 min. The column
was regenerated by washing for 5 min with 100 mM
NaOH/500 mM NaOAc, followed by 5 min with 100
mM NaOH. For PAD the typical quadruple waveform
was used as described previously [32]. The Dionex soft-
ware Chromeleon 6.40 SP8 was used for data acquisition
and data evaluation.
Calculation of kinetic parameters
Vmax and KM were calculated using the curve fit module
of SigmaPlot 11 employing the Michaelis-Menten equa-
tion v = vmax ×cs/(cs +K M).
Siglec-4 binding assay
Murine Siglec-4d1-3-Fc was purified by protein-A affinity
chromatography from tissue culture supernatants of sta-
bly transfected CHO Lec3.2.8.1 as described before [33].
The protein solution was dialyzed against 10 mM phos-
phate buffer pH 7.4, sterile filtered and stored at 4°C.
Binding assays with Siglec-4 were performed as
described previously [33]. In brief, 4 μg/mL fetuin, ASF
or TS-treated fetuin were immobilized in microtitre
plates and binding of serially diluted Siglec-4d1-3-Fc (8
dilutions starting with 16 μg/mL) was determined using
alkaline phosphatase-labeled anti-Fc antibodies. The
concentrations sufficient for 50% binding (relative to
Siglec-4d1-3-Fc binding to fetuin) were determined from
corresponding binding curves. At least three indepen-
dent titrations were performed.
SDS-PAGE and Western Blot analysis
Samples were separated by SDS-PAGE (MiniProtean III;
Bio-Rad, München, Germany) according to Laemmli
[34] and stained with PageBlue.
For Western blot analysis, samples were transferred onto
polyvinylidene difluoride membranes after SDS-PAGE.
The membranes were blocked with 5% BSA in Tris-
buffered saline (TBS) buffer containing 0.15% Tween20
(TBS-T) for 1 h. Washing of the membrane was done five
times for 5 minutes each using TBS-T. Immunodetection
was performed by incubating membranes with a primary
antibody diluted in blocking buffer overnight at 4°C. The
following antibodies were used: anti-T. congolense TS
mAb 7/23 (1:1000) and rabbit anti-Strep-tag (1:1000). Fol-
lowing four washes with TBS-T of 10 minutes each, the
membranes were incubated with a secondary antibody
conjugated to horseradish peroxidase for 2 h at room tem-
perature. After washing four times with TBS-T, blots were
developed with the enhanced chemiluminescence system
using X-ray film.
Matrix-assisted laser desorption ionisation-time of flight
mass spectrometry (MALDI-TOF-MS)
TS reactions were carried out with 50 ng TS, 100 nmol
lactose and 100 μg fetuin as described above. The dried
protein pellets after TS reaction were dissolved in 200 μL
50 mM ammonium hydrogen carbonate, pH 7.8 and 1.6
μL 45 mM DTT were added. After 30 minutes incubation
at 50°C, 1.6 μL 100 mM IAA were added and further incu-
bated for 30 minutes at 37°C. The tryptic digestion was
started with 2 μg trypsin dissolved in 1 μL 50 mM acetic
acid and incubated overnight at 37°C and stored at -20°C.
5 μL of the tryptic digest were mixed with 5 μLH 2O
and 1 μL 1% trifluoroacetic acid and were directly
mixed with matrix and 1 μL was applied to the MALDI-
TOF-MS target plate. The remaining 9 μL were desalted
using C18-reversed phase pipette tips (ZipTip). Peptides
were eluted with 3 × 100 μL 12% and 30% acetonitrile
in H2O and lyophilized. 2,5-Dihydroxybenzoic acid in
0.1% trifluoroacetic acid was used as MALDI matrix.
The dried peptides were directly dissolved in 10 μL
DHB solution and 1 μL of the mixture were spotted to
the target plate for crystallization.
The mass spectrometry was performed using a Voya-
ger DE Pro MALDI-TOF N2-Laser with a wavelength of
337 nm (Applied Biosystems, Foster City, USA). All
spectra were measured in the linear detector mode.
Laser intensities and the number of records per spec-
trum were varied manually.
Voyager software was used for data acquisition and
peak detection. For quantification the peak intensity of
each peptide was determined relative to the non-sialy-
lated glycopeptide 1-32 (3459.66 Da) as internal stan-
dard. This peptide is detected in all spectra of the
sialylation variants of the glycopeptides and is not chan-
ged by TS reaction (Figure 8). All measurements were
repeated for at least three times.
Homology Modeling
A homology model of T. congolense TS1 e-1 was calcu-
lated using the software Yasara 10.11.8 [35-40]. The
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Page 14 of 16crystal structure of T. cruzi TS (UniProt: Q26964; PDB
entry: 3B69), previously reported by Buschiazzo et al.,
2002 [12] was used as the template structure. A benzoy-
lated N-acetylneuraminic acid derivative used as a ligand
for T. cruzi TS in the template structure was kept in the
binding site during the calculation of the homology
model.
The following parameters of the Yasara homology
modeling module were modified manually from the
default settings of the program: Modeling speed: slow,
PsiBLASTs: 6, EValue Max: 0.5, Templates total: 1,
Templates SameSeq: 1, OligoState: 4, alignments: 10,
LoopSamples: 50, TermExtension:10.
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